Preferences
Related Series
Related Segments
Related Products
Related Vendors
Related Articles


PACS 2020
Ability to Scale Drives Decisions, with an Eye on Enterprise Imaging
Current Time Inside Cache Tag Helper: 5/29/2022 1:54:39 AM and Model.reportId = 1677
The PACS market is currently an evolving, dynamic space ripe for disruption—many provider organizations are replacing legacy PACS solutions and enterprise imaging (EI) is on the rise. As provider organizations examine potential vendor partners, the following three considerations are top of mind:- Are current customers satisfied (and does the vendor deliver consistently regardless of client volume)?
- Can the vendor scale to meet the complex needs of large-volume organizations?
- What is the vendor’s EI strategy and how well can they provide EI guidance?
if you don't have a login, getting started is easy.
Key Findings:
- Overall PACS Performance, Scalability, and EI Strategy
- PACS Performance & Consistency
- Sectra and Change Healthcare Consistently Perform Well across Image Volumes
- Ability to Scale to Large Imaging Volumes
- Change Healthcare, Fujifilm, Philips IntelliSpace Scale to >500K; Performance Is Middle of the Road
- For >300K, Sectra and Intelerad (Mostly Imaging Groups) Excel in Key Metrics
- EI Strategy & Guidance
- EI Partnership an Important Factor in PACS Decisions—Is Your Vendor a Partner across Imaging Solutions?
- With Large EI Customer Bases, IBM Watson Health and Agfa HealthCare Seen as Strategic Partners

Writer
Amanda Wind Smith

Designer
Jess Wallace-Simpson
This material is copyrighted. Any organization gaining unauthorized access to this report will be liable to compensate KLAS for the full retail price. Please see the KLAS DATA USE POLICY for information regarding use of this report. © 2022 KLAS Research, LLC. All Rights Reserved. NOTE: Performance scores may change significantly when including newly interviewed provider organizations, especially when added to a smaller sample size like in emerging markets with a small number of live clients. The findings presented are not meant to be conclusive data for an entire client base.